SCHEMBL148063

SCHEMBL148063

Cc1c[nH]c(C(=O)O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL29953274 0.98 NOTUM (0.39)
SCHEMBL28706113 0.86 NOTUM (0.32)
SCHEMBL2854030 0.84 NOTUM (0.32)
SCHEMBL5151745 0.84 NPC1 (0.32)
Bromide SCHEMBL7429002 0.82 NPC1 (0.32)
SCHEMBL1857158 0.80
SCHEMBL19603001 0.78
Zinc Ion SCHEMBL14482007 0.78
SCHEMBL3754899 0.77
SCHEMBL20571366 0.77 CREBBP (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110563980-B Composite proton exchange membrane of carboxylated ZIFs and sulfonated aromatic polymer and preparation method and application thereof 湖北工程学院 2022-04-19 CN claimed
CN-113711029-A Method for the diagnostic and/or prognostic evaluation of chronic plus acute liver failure syndrome in patients suffering from liver disorders 欧洲慢性肝衰竭研究基金会 2021-11-26 CN claimed
CN-112142855-A Protein for diabetes treatment, protein conjugate and application thereof 爱德迪安(北京)生物技术有限公司 2020-12-29 CN claimed
CN-110563980-A composite proton exchange membrane of carboxylated ZIFs and sulfonated aromatic polymer and preparation method and application thereof 湖北工程学院 2019-12-13 CN claimed
CN-109970617-A A series of oligomerization amides and its synthetic method containing N- methylpyrrole and N- methylimidazole 上海茂晟康慧科技有限公司 2019-07-05 CN claimed
CN-104823265-A Compositions of low-K dielectric sols containing non-metallic catalysts SBA MATERIALS INC 2015-08-05 CN claimed
EP-1869019-B1 BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS PFIZER PROD INC (US) 2014-08-27 EP claimed
US-20100286158-A1 DIHYDROPYRIMIDINONES HOFFMANN-LA ROCHE, INC. 2010-11-11 US claimed
WO-2010128058-A1 DIHYDROPYRIMIDINONES FOR USE AS BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO claimed
EP-1869019-A1 BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS Pfizer Products Incorporated (US) 2007-12-26 EP claimed
WO-2006106425-A1 BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS PFIZER PRODUCTS INC. (US) 2006-10-12 WO claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed
WO-2026098637-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2026-05-15 WO disclosed
EP-4569560-A1 AMPHIPHILIC COMPLEXING AGENTS FOR IMPROVED MEMBRANE COMPATIBILITY AND STABILITY OF REDOX SPECIES Wisconsin Alumni Research Foundation (US) 2025-06-18 EP disclosed
EP-4539839-A1 METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES Design Therapeutics, Inc. (US) 2025-04-23 EP disclosed
EP-3848351-B1 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF US HEALTH (US) 2025-01-15 EP disclosed
EP-0885189-A2 METHOD FOR THE SYNTHESIS OF POLY-PYRROLE AND POLY-IMIDAZOLE CARBOXAMIDES ON A SOLID SUPPORT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-12-23 EP disclosed
WO-1998056769-A1 CARBONYLDIIMIDAZOLES, THEIR ESTER DERIVATIVES AND METHOD FOR THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 1998-12-17 WO disclosed
WO-1997030975-A2 METHOD FOR THE SYNTHESIS OF POLY-PYRROLE AND POLY-IMIDAZOLE CARBOXAMIDES ON A SOLID SUPPORT CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1997-08-28 WO disclosed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US disclosed